| The requirements of a specialist breast centre L Biganzoli, F Cardoso, M Beishon, D Cameron, L Cataliotti, CE Coles, ... The Breast 51, 65-84, 2020 | 171 | 2020 |
| Factors affecting gastrointestinal absorption of levothyroxine: a review M Skelin, T Lucijanić, DA Klarić, A Rešić, M Bakula, AM Liberati-Čizmek, ... Clinical therapeutics 39 (2), 378-403, 2017 | 133 | 2017 |
| Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis M Lucijanic, I Veletic, D Rahelic, V Pejsa, D Cicic, M Skelin, A Livun, ... Wiener klinische Wochenschrift 130, 126-133, 2018 | 37 | 2018 |
| Elevated Neutrophil–to–lymphocyte-ratio and platelet–to–lymphocyte ratio in myelofibrosis: Inflammatory biomarkers or representatives of myeloproliferation itself? M Lucijanic, D Cicic, T Stoos-Veic, V Pejsa, J Lucijanic, AF Dzankic, ... Anticancer research 38 (5), 3157-3163, 2018 | 32 | 2018 |
| Patients with higher body mass index treated with direct/novel oral anticoagulants (DOAC/NOAC) for atrial fibrillation experience worse clinical outcomes M Lucijanic, I Jurin, H Jurin, T Lucijanic, B Starcevic, M Skelin, ... International journal of cardiology 301, 90-95, 2020 | 31 | 2020 |
| Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study M Skelin, T Lucijanić, AM Liberati-Čizmek, SM Klobučar, M Lucijanić, ... Endocrine 62, 432-439, 2018 | 31 | 2018 |
| Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: A new perspective on sodium–glucose co-transporter 2 … D Rahelić, E Javor, T Lucijanić, M Skelin Annals of medicine 49 (1), 51-62, 2017 | 27 | 2017 |
| Survival analysis, more than meets the eye M Lucijanic, M Skelin, TL Lucijanic Biochemia medica 27 (1), 14-18, 2017 | 24 | 2017 |
| Once-weekly semaglutide in adults with overweight or obesity E Javor, M Lucijanić, M Skelin The New England journal of medicine 385 (1), 4-4, 2021 | 21 | 2021 |
| Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE P Suton, M Skelin, Z Rakusic, S Dokuzovic, I Luksic European archives of oto-rhino-laryngology 276, 1275-1281, 2019 | 15 | 2019 |
| De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research S Petar, S Marko, L Ivica European archives of oto-rhino-laryngology, 1-5, 2021 | 8 | 2021 |
| Aspirin use and the risk of cancer M Skelin, E Javor, M Lucijanic JAMA oncology 5 (6), 912-913, 2019 | 7 | 2019 |
| Liraglutide in children and teens with type 2 diabetes E Javor, M Skelin, M Lucijanić The New England journal of medicine 381 (18), 1786-1787, 2019 | 7 | 2019 |
| The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients M Skelin, E Javor, M Lucijanić, T Lucijanić, L Jakupović, D Rahelić International journal of clinical practice 72 (12), e13274, 2018 | 7 | 2018 |
| Polypharmacy, potentially inappropriate medications, and drug-to-drug interactions in patients with chronic myeloproliferative neoplasms I Krečak, L Pivac, M Lucijanić, M Skelin Biomedicines 11 (5), 1301, 2023 | 6 | 2023 |
| The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis M Skelin, D Šarčević, D Lešin Gaćina, I Mucalo, I Dilber, E Javor Journal of chemotherapy 35 (2), 150-157, 2023 | 6 | 2023 |
| Smjernice za osobe sa šećernom bolešću i zdravstvene djelatnike koji skrbe o oboljelima od šećerne bolesti u Republici Hrvatskoj u vrijeme COVID-19 pandemije Radne skupine … D Rahelić, T Matić, M Skelin, S Klobučar Majanović, M Bakula, M Deškin, ... Liječnički vjesnik 142 (3-4), 85-88, 2020 | 5 | 2020 |
| Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera I Krecak, M Skelin, S Verstovsek Expert review of hematology 16 (5), 305-316, 2023 | 4 | 2023 |
| Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism I Krečak, K Nižetić, M Čeko, M Skelin, M Lucijanić International journal of laboratory hematology 45 (2), e32-e35, 2023 | 4 | 2023 |
| The economic impact of a clinical pharmacist’s involvement in the hospital medicines policy in a rural area E Javor, A Allouch, J Osvaldić Galic, M Skelin International Journal of Clinical Practice 75 (11), e14859, 2021 | 4 | 2021 |
